Page 31 - ஆய்வகம் நிறுவனம் ஆஃப் அமெரிக்கா ஹோல்டிங்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article ResearchAndMarkets.com s offering. Precision medicine is a concept that collectively integrates the outcomes and the endeavors of research and healthcare. The ability to tailor the diagnostics and therapeutics offered to the patients is the key to precision medicine. The combination of biotechnology development, digitization of healthcare, and public investment led to the evolution of the personalization of disease-based therapies. This evolution within precision medicine will profoundly impact the biopharmaceutical industry, and multiple players from biopharma to diagnostics companies with multiple functions such as research and development to commercial operations will witness a change. The global oncology precision medicine market was valued at $46.90 billion in 2019, and it is expected to grow at an impressive double-digit rate of 11.21% and reach a value of $148.66 billion in 2030.

United statesPacific biosciencesLaura woodAlmac group ltdOther applied sciencesResearch scopeHealth incCalifornia incTeva pharmaceutical industries ltdMdx health incDna detection technologyDigital healthInformation technologyKonica minolta incOpko health incRoche ltd